Gaithersburg, MD, United States of America

Henrik S Olsen

USPTO Granted Patents = 61 (Patent Applications = 1)

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 404(Granted Patents)

Inventors with similar research interests:

Company Filing History:

59 out of 676

Human Genome Sciences, Inc.

patents

1 out of 1

The Institute for Genomic Res.

patent

1 out of 2,198

Smithkline Beecham Corporation

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2013

Loading Chart...

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8372948 - 12 human secreted proteins (2013-02-12),

2. 7482326 - Endothelial-monocyte activating polypeptide III (2009-01-27),

3. 7459531 - 50 Human secreted proteins (2008-12-02),

4. 7393832 - Extracellular/epidermal growth factor like protein (2008-07-01),

5. 7390880 - Soluble interleukin-1 receptor accessory molecule (2008-06-24),

6. 7368244 - Peptidoglycan recognition proteins (2008-05-06),

7. 7326537 - Methods for detecting Corpuscles of Stannius protein stanniocalcin (2008-02-05),

8. 7247442 - Antibodies to HHPEN62 polypeptide (2007-07-24),

9. 7223840 - Antimicrobial peptide (2007-05-29),

10. 7109306 - Antibodies to human oncogene induced secreted protein I (2006-09-19),

11. 7091315 - Protein HDPBQ71 (2006-08-15),

12. 7053190 - Secreted protein HRGDF73 (2006-05-30),

13. 7041802 - Peptidoglycan recognition proteins (2006-05-09),

14. 6974682 - Soluble interleukin-1 receptor accessory molecule (2005-12-13),

15. 6955885 - Human stanniocalcin-alpha (2005-10-18),

Title: Unveiling the Genius of Henrik S Olsen: Pioneering Innovations in Gaithersburg

Introduction: Henrik S Olsen, a prolific inventor based in Gaithersburg, MD, has left an indelible mark on the world of biotechnology with a remarkable portfolio of 61 patents.

Latest Patents: Among his latest patents is the groundbreaking discovery of 12 novel human secreted proteins, along with their isolated nucleic acids and coding regions. These proteins have paved the way for diagnostic and therapeutic methods to address disorders related to human secreted proteins. Additionally, Olsen's work on the endothelial-monocyte activating polypeptide III showcases his dedication to advancing cancer prevention and treatment through innovative recombinant techniques.

Career Highlights: Olsen's career has been intertwined with esteemed organizations such as Human Genome Sciences, Inc., where his visionary research has significantly influenced the field of biomedicine. His relentless pursuit of scientific excellence has led to transformative breakthroughs in understanding human biology and combating diseases.

Collaborations: Throughout his journey, Olsen has collaborated with respected colleagues such as Steven M Ruben and Craig A Rosen, shaping a dynamic network of innovative minds dedicated to pushing the boundaries of scientific exploration.

Conclusion: Henrik S Olsen's impact as an inventor and biotechnologist is truly awe-inspiring, as he continues to redefine the landscape of medical research and innovation. His pioneering spirit serves as a beacon of inspiration for future generations of inventors and researchers, embodying the essence of relentless curiosity and unwavering determination in the pursuit of knowledge and progress.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.